Literature DB >> 8419415

Immunopathogenesis of pulmonary tuberculosis.

A M Dannenberg1.   

Abstract

Antimicrobial therapy quickly eradicates susceptible bacilli, but the fight against drug-resistant disease must be waged entirely by host defenses. Knowledge of the two main types of immune response against tuberculosis and of how to manipulate those mechanisms--leading to precisely designed recombinant BCG vaccines--is essential to mounting an effective attack on the current epidemic.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8419415     DOI： 10.1080/21548331.1993.11442738

Source DB:  PubMed          Journal:  Hosp Pract (Off Ed)        ISSN： 8750-2836


  52 in total

1.  Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish.

Authors:  Hilary Clay; J Muse Davis; Dana Beery; Anna Huttenlocher; Susan E Lyons; Lalita Ramakrishnan
Journal:  Cell Host Microbe       Date:  2007-07-12       Impact factor: 21.023

2.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

3.  Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes.

Authors:  Deborah E Geiman; Tirumalai R Raghunand; Nisheeth Agarwal; William R Bishai
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF.

Authors:  P Chen; R E Ruiz; Q Li; R F Silver; W R Bishai
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Immunopathology of tuberculosis: roles of macrophages and monocytes.

Authors:  M J Fenton; M W Vermeulen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 6.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

7.  A screen for non-coding RNA in Mycobacterium tuberculosis reveals a cAMP-responsive RNA that is expressed during infection.

Authors:  Shaaretha Pelly; William R Bishai; Gyanu Lamichhane
Journal:  Gene       Date:  2012-03-15       Impact factor: 3.688

8.  Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase.

Authors:  Nisheeth Agarwal; Gyanu Lamichhane; Radhika Gupta; Scott Nolan; William R Bishai
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

9.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis.

Authors:  Deborah E Geiman; Deepak Kaushal; Chiew Ko; Sandeep Tyagi; Yukari C Manabe; Benjamin G Schroeder; Robert D Fleischmann; Norman E Morrison; Paul J Converse; Ping Chen; William R Bishai
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.